Has Steven Hochwald, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,858 in general payments to Steven Hochwald, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Hochwald, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Hochwald, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Hochwald, MD

Surgical Oncology · Miami Beach, FLNPI 1912943010

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,575 of the $11,858 with a category attached, or 63.9%. Medical Device Business Services, Inc. accounts for 64.3% of it on its own, with 40 other manufacturers making up the rest. Reporting peaked in 2019 at $7,813 and has fallen 71.4% since, to $2,234 in 2025.

$11,858in general payments, 2019–2025

Across 123 payments — averaging $96.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$8K
Histosonics, Inc.$1K
Johnson & Johnson$382
Daiichi Sankyo Inc.$281
Ipsen Biopharmaceuticals, Inc$265
Merck$178
plus $2K from 35 others

What the payments were for

Consulting fees$7,57564%
Travel & lodging$8377%
Food & beverage$3,44629%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	4	$7,630
Histosonics, Inc.	2	$1,062
Johnson & Johnson(2 entities)	10	$382
Daiichi Sankyo Inc.	12	$281
Ipsen Biopharmaceuticals, Inc	2	$265
Merck	9	$178
Hologic Sales And Service, LLC	1	$160
Taiho Oncology, Inc.	7	$145
AstraZeneca(2 entities)	5	$140
Incyte Corporation	5	$128
Bayer	2	$125
Genentech USA, Inc.	6	$124
EMD Serono, Inc.	5	$105
Eisai Inc.	5	$94
Intuitive Surgical	1	$94
Takeda Pharmaceuticals U.S.A., Inc.	4	$74
Pfizer	4	$73
Springworks Therapeutics, Inc.	3	$67
AVEO Pharmaceuticals, Inc.	3	$62
Servier Pharmaceuticals LLC	3	$59
Adaptive Biotechnologies Corporation	3	$55
Exelixis Inc.	2	$46
Astellas Pharma US Inc	2	$43
Deciphera Pharmaceuticals Inc.	2	$41
Beone Medicines USA, Inc.	2	$41
Pharmacyclics LLC, An Abbvie Company	2	$40
Aimmune Therapeutics, Inc.	1	$39
Stemline Therapeutics Inc.	2	$34
Sanofi	2	$34
AbbVie	1	$34
Sumitomo Pharma America, Inc.	1	$23
Agios Pharmaceuticals, Inc.	1	$23
Recordati_rare_diseases_inc.	1	$20
Myriad Genetic Laboratories, Inc.	1	$19
Jazz Pharmaceuticals Inc.	1	$18
Gilead	1	$18
Lilly USA, LLC	1	$18
Amgen	1	$17
Medtronic	1	$16
Tolmar, Inc.	1	$14
Pharmaand GmbH	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CERTUS 140 MICROWAVE ABLATION SYSTEM$7,575
ECHELON FLEX Stapler$7,575
SOMATULINE DEPOT$265
ONIVYDE$265
TRIDENT SPECIMEN RADIOGRAPHY SYSTEM$160
RYBREVANT$150
CARVYKTI$150
Stivarga$108
Vitrakvi$108

How this compares

$11,858 in reported general payments places this provider in the 80th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida →

Medicare billing

Part B allowed, 2024

$24,538

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Miami Beach

Jessica PastorizaMiami Beach$27K
Juan ParamoMiami Beach$3K
Neha GoelMiami$200K
Jonathan ZagerTampa$191K
Horacio AsbunMiami$161K
Adrian Legaspi SauterHialeah$116K
Kenneth MeredithSarasota$113K
Pamela HodulTampa$94K
Mehran HabibiMiami$73K
Paul BloomstonFort Myers$68K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →